Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Molecular Therapy. Oncology|July 13, 2026
A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemiaSrinivas Vinod Saladi, Swati Garg, Ellen L Weisberg, et al.
Cancer Research|September 23, 2003
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinaseMartin Sattler, Yuri B Pride, Patrick Ma, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|November 24, 2020
Multi-wavelength, handheld laser speckle imaging for skin evaluationMichael Zieger, Martin Kaatz, Steffen Springer, et al.
Blood|August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cellsDharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Cancers|April 13, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple MyelomaBasudev Chowdhury, Swati Garg, Wei Ni, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaKlaus Podar, Giovanni Tonon, Martin Sattler, et al.
Blood Cancer Journal|August 19, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activityJudith Lind, Osman Aksoy, Michaela Prchal-Murphy, et al.
British Journal of Haematology|September 20, 2011
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implicationsKlaus Podar, Alexander Zimmerhackl, Mariateresa Fulciniti, et al.
Pageof 17